Popular on EntSun
- Sexually Abused in a Psychiatric Hospital or Psychiatrist's or Psychologist's Office? CCHR Urges Survivors to Reach Out to It - 198
- Sterling Style Academy Elevates Color Analysis Training and Stylist Certifications with Focus on Transparency - 183
- Connecta Satellite Solutions Ready to Support Emergency Communications Following the Venezuela Earthquake - 160
- Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers - 159
- Sterling Style Academy Announces Standalone Online Color Analysis Training Utilizing Proprietary Three-Dimensional Evaluation Method - 138
- Director Sean McNamara Reunites with Award-Winning Cinematographer Shawn Seifert for Upcoming Feature Home - 136
- New "Lakeside Picnic Ride" Package in Japan's Lake Chuzenji region of Nikko: July 1- November 30, 2026 - 123
- Healthcare Leaders Publish New Integrated Behavioral Healthcare Guide, Led by Doctors of Behavioral Health - 122
- How Sacramento Families Are Using Private Autopsies to Protect Inheritances, Resolve Insurance Claims, and Find Closure - 116
- RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project - 116
Similar on EntSun
- Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
- Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
- CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
- Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
- Lineus Medical Renews Agreement with Vizient, Delivering Enhanced Value for Vizient Members
- Qscription Technologies Appoints Radiology Industry Veteran Elliot Silverman to Advisory Board
- Mr. Hospital Bed Helps Home Care Buyers Find the Right Hospital Bed
- World Cup Crowds Are a Stress Test for America's Restrooms
Dosi Announces the World's Most Capable Peptide, GLP-1 and TRT Tracking App
EntSun News/11098210
Available internationally through the Apple App Store and Google Play, Dosi brings 180+ compound profiles, personal tracking, injection-site history, a reconstitution calculator, and the Ask Dosi intelligence layer in one mobile platform.
ST. AUGUSTINE, Fla. - EntSun -- Dosi, a Health & Fitness app from 3WB Holdings, announced mobile availability on iOS and Android. Built as the world's most capable peptide tracker and personal protocol organizer, Dosi gives people managing complex routines one place for their schedules, logs, reference material, and routine history.
Dosi is available internationally through the Apple App Store and Google Play. Its current public product listings describe features including personal dose logging, schedules and reminders, a body-map record for injection-site rotation, a reconstitution calculator, protocol history, and a 180+ compound reference library.
The platform is designed around personal tracking and educational reference across routine categories represented in Dosi's current public materials, including GLP-1, TRT, HRT, fertility and IVF medication, peptides, growth-hormone routines, nootropics, and longevity-related compounds. For people organizing GLP-1 routines, the app can serve as a semaglutide tracker or tirzepatide tracker. Category coverage is not a medical recommendation, suitability determination, or treatment guidance.
More on EntSun News
Dosi also includes Ask Dosi, an in-app AI intelligence layer described in its current store listings as a research-informed information feature. Ask Dosi is intended to help users find relevant educational and tracking information inside the product; it is not a clinician, does not diagnose or prescribe, and is not a substitute for qualified healthcare guidance.
"People managing complex routines often end up moving between calendars, notes, screenshots, and spreadsheets," said Dean White, Founder and CEO of Dosi. "We built Dosi to give them one place to organize the information they personally track and bring better context to conversations with their qualified healthcare providers."
Dosi's free tier allows users to start organizing a protocol. Premium plans add expanded product features. The app is intended for informational and organizational use only; it does not provide medical advice, diagnosis, or treatment. Users should consult a qualified healthcare provider regarding medical decisions, prescriptions, dosing, or treatment.
More on EntSun News
About Dosi: Dosi is a personal protocol-tracking app for iOS and Android, built by 3WB Holdings in St. Augustine, Florida.
Media Contact: Dosi / 3WB Holdings — press@heydosi.com
Website: https://heydosi.com
Press kit: Dosi Press (https://heydosi.com/en/press?utm_source=prlog&utm_medium=press_release&utm_campaign=dosi_cross_platform_availability_2026_07)
Dosi is available internationally through the Apple App Store and Google Play. Its current public product listings describe features including personal dose logging, schedules and reminders, a body-map record for injection-site rotation, a reconstitution calculator, protocol history, and a 180+ compound reference library.
The platform is designed around personal tracking and educational reference across routine categories represented in Dosi's current public materials, including GLP-1, TRT, HRT, fertility and IVF medication, peptides, growth-hormone routines, nootropics, and longevity-related compounds. For people organizing GLP-1 routines, the app can serve as a semaglutide tracker or tirzepatide tracker. Category coverage is not a medical recommendation, suitability determination, or treatment guidance.
More on EntSun News
- MetroLagoons now accepting bookings for special events, holiday parties
- The Competitive Advantage Isn't Automation. It's Having Lived
- CRG Awarded NASA SEWP VI Contracts in Categories B and C
- KLM Enterprises Services LLC Announces Company-Wide Adoption of ChatGPT and Codex
- The Railyard Event & Conference Center Opens Ticket Box Office in Downtown Elkins
Dosi also includes Ask Dosi, an in-app AI intelligence layer described in its current store listings as a research-informed information feature. Ask Dosi is intended to help users find relevant educational and tracking information inside the product; it is not a clinician, does not diagnose or prescribe, and is not a substitute for qualified healthcare guidance.
"People managing complex routines often end up moving between calendars, notes, screenshots, and spreadsheets," said Dean White, Founder and CEO of Dosi. "We built Dosi to give them one place to organize the information they personally track and bring better context to conversations with their qualified healthcare providers."
Dosi's free tier allows users to start organizing a protocol. Premium plans add expanded product features. The app is intended for informational and organizational use only; it does not provide medical advice, diagnosis, or treatment. Users should consult a qualified healthcare provider regarding medical decisions, prescriptions, dosing, or treatment.
More on EntSun News
- Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
- After 13 Years, High Speed Low Drag Announces U.S. Sneak Preview of Race With The Devil
- Mirada Lagoon to host Tampa 9/11 Heroes Run on Sept. 13
- Elevate Your Sneakers With Crep Protect Trek Laces
- Sarah J. Preston Releases "Larger Than Life" An Urban Legend Art Story Behind Her MultiMedia Empires
About Dosi: Dosi is a personal protocol-tracking app for iOS and Android, built by 3WB Holdings in St. Augustine, Florida.
Media Contact: Dosi / 3WB Holdings — press@heydosi.com
Website: https://heydosi.com
Press kit: Dosi Press (https://heydosi.com/en/press?utm_source=prlog&utm_medium=press_release&utm_campaign=dosi_cross_platform_availability_2026_07)
Source: Dosi / 3WB Holdings
0 Comments
Latest on EntSun News
- Marcus "Big Spence" Spencer Stars Alongside Tom Arnold in New Sci-Fi Thriller "Alien Storm"
- Nick Egan Times Celebrates Five Years Following Times Square New Year's Eve Milestone
- Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
- For Tell an Old Joke Day, Treat Yourself to some very edgy jokes in "Crazy Robert's Joke Book"
- Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
- New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript
- GBAMFS Shares Intellectual Property Feedback and Guidance to US Congress
- The J. Wes Project Celebrates 11 Years of Love, Music & Inspiration
- Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
- Bay Street Yard announces summer menu, happy hour
- Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
- Frankie Sly Takes on New Role as Face of Global Creators' Rights Campaign
- Nina Simone and Samuel Waymon Music Scholarship Fund Opens 2026/27 Application Cycle
- Fatal FOMO May be Your Last Roll of the Dice
- AVNAH Captivates Audiences with a Daring Runway Presentation at ATL SWIM Week 2026 by Avnah Long
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
- London Atelier 'Latexandlovers' Launches 'The Cousteau': High-Fashion Bespoke Latex Clothing
- Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
- 58-Year-Old Gamer Hits Top 25% on YouTube, Earns 3 Creator Awards in Two Weeks
- PokerStars & Ladbrokes veteran buys into Finnish news media Rahapelisanomat